Barbara G McClung sold $4,811 of CRBU
Chief Legal Officer at Caribou Biosciences, Inc.. 3,564 shares at an average of $1.35, traded Feb 21, 2025, filed Feb 21, 2025.
Score components
- +15RoleOfficer
- 0Trade size$5k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231321-25-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | AGrant or award Common Stock | +37,500 | $0.00 | $0 | 447,066 | Feb 21, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock10b5-1 | -3,564 | $1.35 | $4,811 | 443,502 | Feb 21, 2025 |
| Feb 20, 2025 | AGrant or award Option to purchase Common Stockderivative | +170,000 | $0.00 | $0 | 170,000 | Feb 21, 2025 |
Related signals
Other insiders at Caribou Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Caribou Biosciences, Inc. | Timothy P Kelly Chief Technology Officer | $12k 6,228 shares | -8% | |
| 10Weak | Caribou Biosciences, Inc. | Tina M. Albertson Chief Medical Officer | $2,089 1,066 shares | -2% | |
| 10Weak | Caribou Biosciences, Inc. | Barbara G McClung Chief Legal Officer | $14k 6,938 shares | -1% | |
| 30Weak | Caribou Biosciences, Inc. | Timothy P Kelly Chief Technology Officer | $6,168 3,147 shares | -4% | |
| 10Weak | Caribou Biosciences, Inc. | Ruhi Ahmad Khan Chief Business Officer | $14k 6,938 shares | -6% | |
| 20Weak | CRBUbuy Caribou Biosciences, Inc. | Rachel E. Haurwitz President and CEO | $20k 20,000 shares | +1% | |
| 10Weak | Caribou Biosciences, Inc. | Steven Kanner Chief Scientific Officer | $4,811 3,564 shares | -1% | |
| 10Weak | Caribou Biosciences, Inc. | Ruhi Ahmad Khan Chief Business Officer | $4,811 3,564 shares | -5% | |
| 30Weak | CRBUbuy Caribou Biosciences, Inc. | Sriram Ryali Chief Financial Officer | $25k 17,360 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.